Theriva Biologics Inc (TOVX)

[BooDog]

There has been some excellent bio plays and stories in 2016. Overall though the sector has been left in the dirt finding itself wanting. I was going to give an overview of what 2016 did for SYN, the not quite but expected failure of trimesta and all the money spent on that endeavor. The advancement of the pipeline for SYN's 001 & 004 and all that money but really, that's the life of almost any bio. Win some, lose some. And then where does SYN stand now and in the future where is it going? Long term Vs. short term. But simply don't want to take the time, I have a yard full of leaves to clean up. Actually thankful for the chore considering the devastating storms and fires recently that I can spend my time cleaning up and helping a couple friends that are still dealing with the flood that hit our area of Virginia Beach.
Anyway, I think SYN recovers nicely in 2017.